Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 55 entries
Sorted by: Best Match Show Resources per page
Cytogenetic abnormalities in lung cancer.

Cancer treatment and research

Campbell L, Brown J, Garson OM, Morstyn G.
PMID: 2577168
Cancer Treat Res. 1989;45:123-36. doi: 10.1007/978-1-4613-1593-3_8.

No abstract available.

Cite
Campbell L, Brown J, Garson OM, et al. Cytogenetic abnormalities in lung cancer. Cancer Treat Res. 1989;45:123-36doi: 10.1007/978-1-4613-1593-3_8.
Campbell, L., Brown, J., Garson, O. M., & Morstyn, G. (1989). Cytogenetic abnormalities in lung cancer. Cancer treatment and research, 45123-36. https://doi.org/10.1007/978-1-4613-1593-3_8
Campbell, L, et al. "Cytogenetic abnormalities in lung cancer." Cancer treatment and research vol. 45 (1989): 123-36. doi: https://doi.org/10.1007/978-1-4613-1593-3_8
Campbell L, Brown J, Garson OM, Morstyn G. Cytogenetic abnormalities in lung cancer. Cancer Treat Res. 1989;45:123-36. doi: 10.1007/978-1-4613-1593-3_8. PMID: 2577168.
Copy Download .nbib Format: NLM
Focus on lung cancer.

Cancer cell

Minna JD, Roth JA, Gazdar AF.
PMID: 12086887
Cancer Cell. 2002 Feb;1(1):49-52. doi: 10.1016/s1535-6108(02)00027-2.

No abstract available.

Cite
Minna JD, Roth JA, Gazdar AF. Focus on lung cancer. Cancer Cell. 2002;1(1):49-52doi: 10.1016/s1535-6108(02)00027-2.
Minna, J. D., Roth, J. A., & Gazdar, A. F. (2002). Focus on lung cancer. Cancer cell, 1(1), 49-52. https://doi.org/10.1016/s1535-6108(02)00027-2
Minna, John D, et al. "Focus on lung cancer." Cancer cell vol. 1,1 (2002): 49-52. doi: https://doi.org/10.1016/s1535-6108(02)00027-2
Minna JD, Roth JA, Gazdar AF. Focus on lung cancer. Cancer Cell. 2002 Feb;1(1):49-52. doi: 10.1016/s1535-6108(02)00027-2. PMID: 12086887.
Copy Download .nbib Format: NLM
[Lung cancer].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine

Chikumi H, Shimizu E.
PMID: 12924271
Nihon Naika Gakkai Zasshi. 2003 Jul 10;92(7):1255-65.

No abstract available.

Cite
Chikumi H, Shimizu E. [Lung cancer]. Nihon Naika Gakkai Zasshi. 2003;92(7):1255-65
Chikumi, H., & Shimizu, E. (2003). [Lung cancer]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 92(7), 1255-65.
Chikumi, Hiroki, and Shimizu, Eiji. "[Lung cancer]." Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine vol. 92,7 (2003): 1255-65.
Chikumi H, Shimizu E. [Lung cancer]. Nihon Naika Gakkai Zasshi. 2003 Jul 10;92(7):1255-65. Japanese. PMID: 12924271.
Copy Download .nbib Format: NLM
Reply to Lambros et al.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Tang Z, Zhang J, Chen H, Lu S, Cheng J, Tang G, Medeiros LJ.
PMID: 29515243
Mod Pathol. 2018 Mar;31(3):541-542. doi: 10.1038/modpathol.2017.192.

No abstract available.

Cite
Tang Z, Zhang J, Chen H, et al. Reply to Lambros et al. Mod Pathol. 2018;31(3):541-542doi: 10.1038/modpathol.2017.192.
Tang, Z., Zhang, J., Chen, H., Lu, S., Cheng, J., Tang, G., & Medeiros, L. J. (2018). Reply to Lambros et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 31(3), 541-542. https://doi.org/10.1038/modpathol.2017.192
Tang, Zhenya, et al. "Reply to Lambros et al." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. 31,3 (2018): 541-542. doi: https://doi.org/10.1038/modpathol.2017.192
Tang Z, Zhang J, Chen H, Lu S, Cheng J, Tang G, Medeiros LJ. Reply to Lambros et al. Mod Pathol. 2018 Mar;31(3):541-542. doi: 10.1038/modpathol.2017.192. PMID: 29515243.
Copy Download .nbib Format: NLM
Diagnosis and Molecular Classification of Lung Cancer.

Cancer treatment and research

Rodriguez-Canales J, Parra-Cuentas E, Wistuba II.
PMID: 27535388
Cancer Treat Res. 2016;170:25-46. doi: 10.1007/978-3-319-40389-2_2.

Lung cancer is a complex disease composed of diverse histological and molecular types with clinical relevance. The advent of large-scale molecular profiling has been helpful to identify novel molecular targets that can be applied to the treatment of particular...

Cite
Rodriguez-Canales J, Parra-Cuentas E, Wistuba II. Diagnosis and Molecular Classification of Lung Cancer. Cancer Treat Res. 2016;170:25-46doi: 10.1007/978-3-319-40389-2_2.
Rodriguez-Canales, J., Parra-Cuentas, E., & Wistuba, I. I. (2016). Diagnosis and Molecular Classification of Lung Cancer. Cancer treatment and research, 17025-46. https://doi.org/10.1007/978-3-319-40389-2_2
Rodriguez-Canales, Jaime, et al. "Diagnosis and Molecular Classification of Lung Cancer." Cancer treatment and research vol. 170 (2016): 25-46. doi: https://doi.org/10.1007/978-3-319-40389-2_2
Rodriguez-Canales J, Parra-Cuentas E, Wistuba II. Diagnosis and Molecular Classification of Lung Cancer. Cancer Treat Res. 2016;170:25-46. doi: 10.1007/978-3-319-40389-2_2. PMID: 27535388.
Copy Download .nbib Format: NLM
A Decade of GWAS Results in Lung Cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Bossé Y, Amos CI.
PMID: 28615365
Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):363-379. doi: 10.1158/1055-9965.EPI-16-0794. Epub 2017 Jun 14.

Genome-wide association studies (GWAS) were successful to identify genetic factors robustly associated with lung cancer. This review aims to synthesize the literature in this field and accelerate the translation of GWAS discoveries into results that are closer to clinical...

Cite
Bossé Y, Amos CI. A Decade of GWAS Results in Lung Cancer. Cancer Epidemiol Biomarkers Prev. 2017;27(4):363-379doi: 10.1158/1055-9965.EPI-16-0794.
Bossé, Y., & Amos, C. I. (2018). A Decade of GWAS Results in Lung Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 27(4), 363-379. https://doi.org/10.1158/1055-9965.EPI-16-0794
Bossé, Yohan, and Amos, Christopher I. "A Decade of GWAS Results in Lung Cancer." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 27,4 (2018): 363-379. doi: https://doi.org/10.1158/1055-9965.EPI-16-0794
Bossé Y, Amos CI. A Decade of GWAS Results in Lung Cancer. Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):363-379. doi: 10.1158/1055-9965.EPI-16-0794. Epub 2017 Jun 14. PMID: 28615365; PMCID: PMC6464125.
Copy Download .nbib Format: NLM
Quantitative proteomics in lung cancer.

Journal of biomedical science

Cheung CHY, Juan HF.
PMID: 28615068
J Biomed Sci. 2017 Jun 14;24(1):37. doi: 10.1186/s12929-017-0343-y.

Lung cancer is the most common cause of cancer-related death worldwide, less than 7% of patients survive 10 years following diagnosis across all stages of lung cancer. Late stage of diagnosis and lack of effective and personalized medicine reflect...

Cite
Cheung CHY, Juan HF. Quantitative proteomics in lung cancer. J Biomed Sci. 2017;24(1):37doi: 10.1186/s12929-017-0343-y.
Cheung, C. H. Y., & Juan, H. F. (2017). Quantitative proteomics in lung cancer. Journal of biomedical science, 24(1), 37. https://doi.org/10.1186/s12929-017-0343-y
Cheung, Chantal Hoi Yin, and Juan, Hsueh-Fen. "Quantitative proteomics in lung cancer." Journal of biomedical science vol. 24,1 (2017): 37. doi: https://doi.org/10.1186/s12929-017-0343-y
Cheung CHY, Juan HF. Quantitative proteomics in lung cancer. J Biomed Sci. 2017 Jun 14;24(1):37. doi: 10.1186/s12929-017-0343-y. PMID: 28615068; PMCID: PMC5470322.
Copy Download .nbib Format: NLM
[Molecular pathologic diagnosis of lung cancer requires basic knowledge also from clinicians].

Duodecim; laaketieteellinen aikakauskirja

Lappi-Blanco E, Salmenkivi K, Kytölä S, Kononen J.
PMID: 27132299
Duodecim. 2016;132(6):593-9.

Besides histological classification of lung cancers, molecular biological examination of tumors is part of modern diagnostics of lung cancers, and cancer therapies are based on molecular biological diagnosis. Current laboratory technique enables the examination of many mutations as part...

Cite
Lappi-Blanco E, Salmenkivi K, Kytölä S, et al. Keuhkosyövän molekyylipatologinen diagnostiikka edellyttää perustietoja myös kliinikoilta. [Molecular pathologic diagnosis of lung cancer requires basic knowledge also from clinicians]. Duodecim. 2016;132(6):593-9
Lappi-Blanco, E., Salmenkivi, K., Kytölä, S., & Kononen, J. (2016). Keuhkosyövän molekyylipatologinen diagnostiikka edellyttää perustietoja myös kliinikoilta. [Molecular pathologic diagnosis of lung cancer requires basic knowledge also from clinicians]. Duodecim; laaketieteellinen aikakauskirja, 132(6), 593-9.
Lappi-Blanco, Elisa, et al. "Keuhkosyövän molekyylipatologinen diagnostiikka edellyttää perustietoja myös kliinikoilta." [Molecular pathologic diagnosis of lung cancer requires basic knowledge also from clinicians]. Duodecim; laaketieteellinen aikakauskirja vol. 132,6 (2016): 593-9.
Lappi-Blanco E, Salmenkivi K, Kytölä S, Kononen J. Keuhkosyövän molekyylipatologinen diagnostiikka edellyttää perustietoja myös kliinikoilta. [Molecular pathologic diagnosis of lung cancer requires basic knowledge also from clinicians]. Duodecim. 2016;132(6):593-9. Finnish. PMID: 27132299.
Copy Download .nbib Format: NLM
Note of clarification of data in the paper titled X-ray repair cross-complementing group 1 Arg194Trp polymorphism is associated with increased risk of lung cancer in Chinese Han population.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Yang H, Feng R, Wang H, Wang Y.
PMID: 25669171
Tumour Biol. 2015 Apr;36(4):2229-33. doi: 10.1007/s13277-015-3201-0. Epub 2015 Feb 11.

No abstract available.

Cite
Yang H, Feng R, Wang H, et al. Note of clarification of data in the paper titled X-ray repair cross-complementing group 1 Arg194Trp polymorphism is associated with increased risk of lung cancer in Chinese Han population. Tumour Biol. 2015;36(4):2229-33doi: 10.1007/s13277-015-3201-0.
Yang, H., Feng, R., Wang, H., & Wang, Y. (2015). Note of clarification of data in the paper titled X-ray repair cross-complementing group 1 Arg194Trp polymorphism is associated with increased risk of lung cancer in Chinese Han population. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 36(4), 2229-33. https://doi.org/10.1007/s13277-015-3201-0
Yang, Haiyan, et al. "Note of clarification of data in the paper titled X-ray repair cross-complementing group 1 Arg194Trp polymorphism is associated with increased risk of lung cancer in Chinese Han population." Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine vol. 36,4 (2015): 2229-33. doi: https://doi.org/10.1007/s13277-015-3201-0
Yang H, Feng R, Wang H, Wang Y. Note of clarification of data in the paper titled X-ray repair cross-complementing group 1 Arg194Trp polymorphism is associated with increased risk of lung cancer in Chinese Han population. Tumour Biol. 2015 Apr;36(4):2229-33. doi: 10.1007/s13277-015-3201-0. Epub 2015 Feb 11. PMID: 25669171.
Copy Download .nbib Format: NLM
[Research Progress in Diagnosis and Management Strategies 
of Multiple Primary Lung Cancer].

Zhongguo fei ai za zhi = Chinese journal of lung cancer

Guo H, Shen-Tu Y.
PMID: 27215460
Zhongguo Fei Ai Za Zhi. 2016 May 20;19(5):307-11. doi: 10.3779/j.issn.1009-3419.2016.05.12.

Although the morbidity of multiple primary lung cancer (MPLC) has been increasing year by year, it is still controversial about pathogenesis, differential diagnosis and management strategies of MPLC. This review provides a snapshot of the main progress of pathogenesis,...

Cite
Guo H, Shen-Tu Y. [Research Progress in Diagnosis and Management Strategies 
of Multiple Primary Lung Cancer]. Zhongguo Fei Ai Za Zhi. 2016;19(5):307-11doi: 10.3779/j.issn.1009-3419.2016.05.12.
Guo, H., & Shen-Tu, Y. (2016). [Research Progress in Diagnosis and Management Strategies 
of Multiple Primary Lung Cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer, 19(5), 307-11. https://doi.org/10.3779/j.issn.1009-3419.2016.05.12
Guo, Haifa, and Shen-Tu, Yang. "[Research Progress in Diagnosis and Management Strategies 
of Multiple Primary Lung Cancer]." Zhongguo fei ai za zhi = Chinese journal of lung cancer vol. 19,5 (2016): 307-11. doi: https://doi.org/10.3779/j.issn.1009-3419.2016.05.12
Guo H, Shen-Tu Y. [Research Progress in Diagnosis and Management Strategies 
of Multiple Primary Lung Cancer]. Zhongguo Fei Ai Za Zhi. 2016 May 20;19(5):307-11. doi: 10.3779/j.issn.1009-3419.2016.05.12. Chinese. PMID: 27215460; PMCID: PMC5973054.
Copy Download .nbib Format: NLM
The evolution of tumor classification: a role for genomics?.

Cancer cell

Bunn PA, Franklin W, Doebele RC.
PMID: 24332038
Cancer Cell. 2013 Dec 09;24(6):693-4. doi: 10.1016/j.ccr.2013.11.019.

Lung cancers are divided into four types according to their histologic appearance. Therapeutic decisions are partly based on histology. A recent study indicates that certain molecular alterations associate with histology and that therapies directed to these molecular changes improve...

Cite
Bunn PA, Franklin W, Doebele RC. The evolution of tumor classification: a role for genomics?. Cancer Cell. 2013;24(6):693-4doi: 10.1016/j.ccr.2013.11.019.
Bunn, P. A., Franklin, W., & Doebele, R. C. (2013). The evolution of tumor classification: a role for genomics?. Cancer cell, 24(6), 693-4. https://doi.org/10.1016/j.ccr.2013.11.019
Bunn, Paul A, et al. "The evolution of tumor classification: a role for genomics?." Cancer cell vol. 24,6 (2013): 693-4. doi: https://doi.org/10.1016/j.ccr.2013.11.019
Bunn PA, Franklin W, Doebele RC. The evolution of tumor classification: a role for genomics?. Cancer Cell. 2013 Dec 09;24(6):693-4. doi: 10.1016/j.ccr.2013.11.019. PMID: 24332038; PMCID: PMC3928679.
Copy Download .nbib Format: NLM
Fire without smoke: lung cancer in 'never-smokers'.

Oncology (Williston Park, N.Y.)

Doran E, Jackman D.
PMID: 20187320
Oncology (Williston Park). 2010 Jan;24(1):40, 43.

No abstract available.

Cite
Doran E, Jackman D. Fire without smoke: lung cancer in 'never-smokers'. Oncology (Williston Park). 2010;24(1):40, 43
Doran, E., & Jackman, D. (2010). Fire without smoke: lung cancer in 'never-smokers'. Oncology (Williston Park, N.Y.), 24(1), 40, 43.
Doran, Elizabeth, and Jackman, David. "Fire without smoke: lung cancer in 'never-smokers'." Oncology (Williston Park, N.Y.) vol. 24,1 (2010): 40, 43.
Doran E, Jackman D. Fire without smoke: lung cancer in 'never-smokers'. Oncology (Williston Park). 2010 Jan;24(1):40, 43. PMID: 20187320.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 55 entries